CYBIN INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.63 CAD | -6.07% |
|
+17.41% | +76.51% |
| Jun. 26 | Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| Jun. 11 | Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development | CI |
Chart calendar Cybin Inc.
500a889b9388f55.ju9vVT53gJs2sFAwCvGSwEuRyQSoSnanmiSW33R4RqU.27hYYF0A0sFZxgdpeoPKry_2rFXnLzL07G3ljDhIDsTq1gQPCCXp436HEQ~d6450f5f2cda3214f028b216292dfe62
Upcoming events on Cybin Inc.
Past events on Cybin Inc.
| 2024-07-05 04:20 am | Interdisciplinary Psychedelic Research Conference - Panel |
| 2024-06-27 07:00 am | H.C. Wainwright Neuro Perspectives Virtual Conference |
| 2024-06-26 07:41 am | Q4 2024 Earnings Release |
| 2024-06-08 08:20 am | Interdisciplinary Psychedelic Research Conference - Panel |
| 2024-06-06 08:40 am | Interdisciplinary Psychedelic Research Conference |
| 2024-06-05 04:20 am | Interdisciplinary Psychedelic Research Conference - Panel |
| 2024-05-21 12:40 pm | Alliance Global Partners Healthcare Showcase |
| 2024-05-08 01:00 pm | Milken Institute Global Conference |
| 2024-04-16 01:30 pm | Bloom Burton & Co. Healthcare Investor Conference |
| 2024-03-19 04:05 pm | Public Ventures Discovery Day |
| 2024-03-13 08:30 am | CYB003 Phase 2 Trial Results Call |
| 2024-03-04 12:50 pm | TD Cowen Health Care Conference |
| 2024-02-14 07:34 am | Q3 2024 Earnings Release |
| 2023-12-02 | American College of Neuropsychopharmacology Meeting - Poster Number: M32 |
| 2023-12-02 | American College of Neuropsychopharmacology Meeting - Poster Number: M83 |
| 2023-12-02 | American College of Neuropsychopharmacology Meeting - Poster Number: M147 |
| 2023-11-30 10:00 am | R&D Day |
| 2023-11-14 07:16 pm | Q2 2024 Earnings Release |
| 2023-11-10 | Society for Neuroscience Meeting |
| 2023-11-07 09:00 am | Milken Institute Future of Health Summit |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 | 0,86 0,59 46.94% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 | -19,2 -14,7 -30.34% | -45,6 -42,6 -7.06% | -46,6 -43,7 -6.71% | -78,4 -67,4 -16.42% | -84,0 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 | -32,3 -24,6 -31.07% | -63,8 -59,3 -7.64% | -51,5 -50,8 -1.43% | -78,8 -68,9 -14.4% | -77,0 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 | -32,2 -26,4 -22.05% | -67,6 -59,2 -14.29% | -47,5 -47,0 -0.97% | -78,1 -74,7 -4.54% | -77,1 |
|
Net income Million CAD | Released Forecast Spread | -0,81 | -32,2 -33,4 3.68% | -67,6 -63,9 -5.89% | -47,5 -46,7 -1.72% | -78,1 -74,5 -4.75% | -77,1 |
|
EPS CAD | Released Forecast Spread | 0,00 | -0,32 -0,23 -41.17% | -0,40 -0,37 -8.11% | -0,26 -0,24 -9.09% | -0,25 -0,24 -5.63% | -0,09 |
| Announcement Date | 09/11/20 | 28/06/21 | 22/06/22 | 27/06/23 | 26/06/24 | - |
Quarterly results
| Fiscal Period | March | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -13,0 -10,0 -28.97% | -11,2 -10,1 -11.29% | -11,2 -10,7 -4.67% | -11,0 -11,6 5.13% | -13,2 -11,3 -16.15% | -12,6 -12,8 1.27% | -13,8 -12,7 -9.4% | -26,9 -13,6 -97.66% | -25,1 -14,0 -79.59% | -17,8 | -17,8 | -24,3 | -24,3 |
|
EBIT Million CAD | Released Forecast Spread | -16,3 -15,9 -2.97% | -13,4 -16,5 18.73% | -12,3 -14,3 13.78% | -12,1 -13,2 8.08% | -13,7 -13,2 -3.78% | -12,7 -13,0 2.49% | -13,9 -12,7 -9.56% | -27,0 -13,8 -95.71% | -25,2 -18,0 -40.02% | -18,0 | -18,0 | -24,5 | -24,5 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -18,1 -15,5 -17.06% | -13,1 -16,1 18.92% | -9,97 -14,4 30.6% | -10,7 -13,2 18.35% | -13,7 -12,8 -7.57% | -14,5 -12,6 -15.36% | -11,9 -12,2 2.81% | -30,3 -14,0 -116.21% | -21,3 -18,0 -18.81% | -16,2 | -16,3 | -23,0 | -23,1 |
|
Net income Million CAD | Released Forecast Spread | -18,1 -15,6 -16.08% | -13,1 -16,7 21.99% | -10,0 -13,6 26.69% | -10,7 -13,3 19.19% | -13,7 -12,6 -8.64% | -14,5 -12,8 -13.82% | -11,9 -12,2 2.81% | -30,3 -14,0 -116.21% | -21,3 -18,4 -16.31% | -16,2 | -16,3 | -23,0 | -23,1 |
|
EPS CAD | Released Forecast Spread | -0,10 -0,09 -15.94% | -0,07 -0,09 22.22% | -0,06 -0,07 12.5% | -0,06 -0,07 14.29% | -0,07 -0,06 -16.67% | -0,07 -0,06 -20.01% | -0,05 -0,05 0% | -0,09 -0,04 -150% | -0,02 -0,04 52% | -0,02 | -0,02 | -0,03 | -0,03 |
| Announcement Date | 22/06/22 | 08/08/22 | 14/11/22 | 14/02/23 | 27/06/23 | 14/08/23 | 14/11/23 | 14/02/24 | 26/06/24 | - | - | - | - |
More events
Past sector events for Cybin Inc.
| 2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYBN Stock
- CLXP.F Stock
- Calendar Cybin Inc.
